However, a 2025 HSS Journal systematic review (544 articles screened, 36 included 35 preclinical, 1 clinical) concluded that high-quality clinical evidence remains limited and use should be approached with caution
View source Joana Nicolau, Jorge Blanco-Anesto, Aina Bonet, Juan Jos Flix-Jaume, Apolonia Gil-Palmer
Starting Blocks 45 11.6
Programs discussed may include BPC-157 , TB-500 , GHK-Cu , GLOW Blend , Sermorelin , Tesamorelin , Ipamorelin , CJC-1295 , and additional wellness-focused peptides when clinically appropriate
Ipamorelin, a new growth hormone releasing peptide with selectivity for the growth hormone secretagogue receptor
GLP-1 drugs were developed and FDA approved for specific medical indications, including type 2 diabetes management and, for certain products, chronic weight management in obese adults and other eligible patients